Concepedia
Statistics
Publications
33
Citations
3.4K
H-Index
30
Active since
1997
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Novartis (United States)
Novartis (China)
University of Liverpool
Amanda Littlewood‐Evans is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and immunology.
Publications per year
1997–2023
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis
Amanda Littlewood‐Evans, Sophie Sarret, Verena Apfel et al. · The Journal of Experimental Medicine · 2016 · 494 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization
Kenneth R. LaMontagne, Amanda Littlewood‐Evans, Christian Schnell et al. · Cancer Research · 2006 · 298 citations
Medicine, Oncology, Pharmacology +17
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Heidi A. Lane, Jeanette M. Wood, Paul M.J. McSheehy et al. · Clinical Cancer Research · 2009 · 251 citations · Full text
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases
Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 216 citations · Full text
Medicine, Nephrology, Pharmacology +17
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis
Joschka Willemsen, Marie‐Therese Neuhoff, Thomas Hoyler et al. · Cell Reports · 2021 · 214 citations · Full text
1–5 of 33